{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladie gravidique précoce : Questions médicales les plus fréquentes",
"headline": "Maladie gravidique précoce : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladie gravidique précoce : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladie gravidique précoce"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vomissement",
"url": "https://questionsmedicales.fr/mesh/D014839",
"about": {
"@type": "MedicalCondition",
"name": "Vomissement",
"code": {
"@type": "MedicalCode",
"code": "D014839",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821.937"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hyperémèse gravidique",
"alternateName": "Hyperemesis Gravidarum",
"url": "https://questionsmedicales.fr/mesh/D006939",
"about": {
"@type": "MedicalCondition",
"name": "Hyperémèse gravidique",
"code": {
"@type": "MedicalCode",
"code": "D006939",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821.937.049.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladie gravidique précoce",
"alternateName": "Morning Sickness",
"code": {
"@type": "MedicalCode",
"code": "D048968",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dae Yul Kim",
"url": "https://questionsmedicales.fr/author/Dae%20Yul%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Min Ho Chun",
"url": "https://questionsmedicales.fr/author/Min%20Ho%20Chun",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "JaYoung Kim",
"url": "https://questionsmedicales.fr/author/JaYoung%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "T Requena",
"url": "https://questionsmedicales.fr/author/T%20Requena",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Biotecnología y Microbiología de Alimentos, Instituto de Investigación en Ciencias de la Alimentación (CIAL-CSIC), Madrid, España. Electronic address: t.requena@csic.es."
}
},
{
"@type": "Person",
"name": "M Velasco",
"url": "https://questionsmedicales.fr/author/M%20Velasco",
"affiliation": {
"@type": "Organization",
"name": "Sección de Enfermedades Infecciosas, Medicina Interna, Hospital Universitario Fundación Alcorcón, Alcorcón, España."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37193776",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41391-023-00675-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36730281",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0278931"
}
},
{
"@type": "ScholarlyArticle",
"name": "The association between prostatitis and risk of prostate cancer: a National Health Insurance Database study.",
"datePublished": "2022-10-06",
"url": "https://questionsmedicales.fr/article/36201020",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00345-022-04165-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia.",
"datePublished": "2022-10-05",
"url": "https://questionsmedicales.fr/article/36198834",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00432-022-04380-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39195294",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/curroncol31080311"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Signes et symptômes digestifs",
"item": "https://questionsmedicales.fr/mesh/D012817"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vomissement",
"item": "https://questionsmedicales.fr/mesh/D014839"
},
{
"@type": "ListItem",
"position": 6,
"name": "Maladie gravidique précoce",
"item": "https://questionsmedicales.fr/mesh/D048968"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladie gravidique précoce - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladie gravidique précoce",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladie gravidique précoce",
"description": "Comment diagnostiquer la maladie gravidique précoce ?\nQuels examens sont nécessaires pour le diagnostic ?\nQuand consulter un médecin pour des nausées ?\nLes nausées matinales sont-elles normales ?\nPeut-on confondre avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladie gravidique précoce",
"description": "Quels sont les symptômes typiques ?\nLes symptômes varient-ils d'une femme à l'autre ?\nLes nausées surviennent-elles à tout moment ?\nY a-t-il des symptômes associés ?\nLes vomissements sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladie gravidique précoce",
"description": "Peut-on prévenir les nausées matinales ?\nQuels aliments éviter pour réduire les symptômes ?\nLe stress influence-t-il les nausées ?\nL'hydratation aide-t-elle à prévenir les nausées ?\nLes vitamines peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladie gravidique précoce",
"description": "Quels traitements sont disponibles ?\nLes remèdes naturels sont-ils efficaces ?\nQuand utiliser des médicaments ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils sûrs pendant la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladie gravidique précoce",
"description": "Quelles complications peuvent survenir ?\nComment reconnaître une complication ?\nLes complications affectent-elles le bébé ?\nQuelles sont les conséquences d'une déshydratation ?\nL'hyperémèse gravidique est-elle fréquente ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladie gravidique précoce",
"description": "Quels sont les facteurs de risque connus ?\nL'âge de la mère influence-t-il les nausées ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?\nLes femmes fumeuses sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la maladie gravidique précoce ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes rapportés par la patiente et l'exclusion d'autres causes."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun examen spécifique n'est requis, mais des analyses sanguines peuvent être faites si nécessaire."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des nausées ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter si les nausées sont sévères ou persistent au-delà du premier trimestre."
}
},
{
"@type": "Question",
"name": "Les nausées matinales sont-elles normales ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont fréquentes et généralement considérées comme normales durant la grossesse."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est important d'exclure d'autres causes comme des infections ou des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes typiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, vomissements, fatigue et hypersensibilité aux odeurs."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une femme à l'autre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement entre les femmes."
}
},
{
"@type": "Question",
"name": "Les nausées surviennent-elles à tout moment ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que souvent matinales, les nausées peuvent survenir à tout moment de la journée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des maux de tête ou des changements d'humeur peuvent également apparaître."
}
},
{
"@type": "Question",
"name": "Les vomissements sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vomissements peuvent survenir chez certaines femmes, mais ne sont pas systématiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les nausées matinales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie, mais des changements alimentaires peuvent aider."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pour réduire les symptômes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments gras, épicés et les odeurs fortes qui peuvent aggraver les nausées."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les nausées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes, il est donc conseillé de pratiquer des techniques de relaxation."
}
},
{
"@type": "Question",
"name": "L'hydratation aide-t-elle à prévenir les nausées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, rester bien hydraté peut aider à réduire l'intensité des nausées."
}
},
{
"@type": "Question",
"name": "Les vitamines peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vitamines, comme la vitamine B6, peuvent aider à réduire les symptômes chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des changements alimentaires, des médicaments anti-nauséeux et l'hydratation."
}
},
{
"@type": "Question",
"name": "Les remèdes naturels sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des remèdes comme le gingembre ou les tisanes peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quand utiliser des médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments sont recommandés si les symptômes sont sévères et affectent la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent avoir des effets secondaires, il est donc important de consulter."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils sûrs pendant la grossesse ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La plupart des traitements sont considérés comme sûrs, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la déshydratation ou l'hyperémèse gravidique peuvent survenir dans les cas graves."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des vomissements fréquents, une perte de poids ou des douleurs abdominales nécessitent une consultation."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le bébé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, des complications peuvent affecter la santé du bébé, d'où l'importance d'un suivi médical."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une déshydratation ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation peut entraîner des complications graves, y compris des problèmes rénaux et des déséquilibres électrolytiques."
}
},
{
"@type": "Question",
"name": "L'hyperémèse gravidique est-elle fréquente ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'hyperémèse gravidique est rare mais nécessite une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents de nausées dans des grossesses précédentes et des grossesses multiples."
}
},
{
"@type": "Question",
"name": "L'âge de la mère influence-t-il les nausées ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes plus jeunes, notamment celles de moins de 20 ans, peuvent être plus à risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de nausées matinales peut augmenter le risque chez la mère."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress émotionnel et physique peut augmenter la probabilité de développer des nausées."
}
},
{
"@type": "Question",
"name": "Les femmes fumeuses sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut influencer l'intensité des nausées matinales chez certaines femmes."
}
}
]
}
]
}
Patient outcomes were assessed based on a pre-biopsy ExoDx Prostate (EPI) score at 2.5 years of the 5-year follow-up of ongoing prostate biopsy Decision Impact Trial of the ExoDx Prostate (IntelliScor...
Prospective, blinded, randomized, multisite clinical utility study was conducted from June 2017 to May 2018 (NCT03235687). Urine samples were collected from 1049 men (≥50 years old) with a PSA 2-10 ng...
At 2.5 years, 833 patients had follow-up data. In the EPI arm, biopsy rates remained lower for low-risk EPI scores than high-risk EPI scores (44.6% vs 79.0%, p < 0.001), whereas biopsy rates were iden...
This follow-up analysis captures subsequent biopsy outcomes and demonstrates that men receiving EPI low-risk scores (<15.6) significantly defer the time to first biopsy and remain at a very low pathol...
There is no consensus on the management plan for incidental prostate cancer (IPCa) after holmium laser enucleation of the prostate (HoLEP). This study aims to investigate the natural course of this di...
The medical records of a prospective cohort of patients with LUTS/BPH who underwent HoLEP between July 2008 and December 2020 at Seoul National University Hospital were retrospectively reviewed. Patie...
Among 2630 patients, 141 (5.4%) were diagnosed with IPCa after HoLEP. Pathologic T stage and magnetic resonance imaging results were highly associated with the physician's primary treatment decision-m...
The incidence of IPCa after HoLEP was 5.4%, and among these, approximately 20% proceeded with immediate definitive therapy and an additional 6% ultimately received definitive therapy within a median o...
Inflammation is thought to affect the development of prostate cancer (PCa). By retrospectively investigating the database of the National Health Insurance Service, this study attempted to perform a re...
Participants were aged ≥ 50 years. Patients diagnosed with prostatitis between 2010 and 2013 and matched controls were followed up until 2019. We selected controls with matched propensity scores for a...
A total of 746,176 patients from each group were analyzed. The incidence of PCa was significantly higher in the group with prostatitis (1.8% vs 0.6%, p < 0.001). The HR for PCa was significantly highe...
Prostatitis is associated with an increased incidence of PCa. Acute prostatitis is associated with higher risk of PCa than chronic prostatitis. Clinicians should inform patients with prostatitis that ...
Markers are needed to increase the diagnostic accuracy of prostate-specific antigen (PSA) in prostate cancer (PCa) screening. Mounting evidence has shown that plasma proteins can be hopeful biomarkers...
Tandem mass tag (TMT)-based proteomics and parallel reaction monitoring (PRM) analysis were used to screen the differential proteins and further validated in other independent studies (n = 539). Recei...
Three candidate proteins (DBP, LCAT and ORM2) were preliminarily screened. Subsequent validation studies revealed significant upregulation of ORM2 in PCa patients across other independent cohorts. ORM...
In summary, our study suggests that ORM2 could be treated as a complementary biomarker for PSA in distinguishing PCa from BPH....
Prostate cancer represents a significant public health challenge, with its management requiring precise diagnostic and prognostic tools. Prostate-specific membrane antigen (PSMA), a cell surface enzym...
To analyse multiparametric magnetic resonance imaging (mpMRI) characteristics and appearance of histopathologically proven non-cancerous intraprostatic findings focussing on quantity of prostatitis an...
In this retrospective analysis consecutive patients with mpMRI followed by MRI/TRUS-fusion biopsy comprising targeted (TB) and systematic biopsy (SB) cores without prostate cancer (PC) at histopatholo...
Seventy-two patients were analysed. The median baseline characteristics were PSA 5.4 ng/ml (4.0-7.9), PI-RADS classification 3 (2-4), prostate volume 43 ml (33-57), and PSA density 0.13 ng/ml...
Quantity of atrophy and prostatitis had different influence on MRI characteristics and increased within higher PI-RADS classification. Younger men had diffuse hypointense changes at T2w images, but le...
The impact of prostate radiotherapy on patient-reported health-related quality of life (HRQoL) significantly influences the outcomes of metastatic prostate cancer. We measured and compared HRQoL of me...
Between November 23, 2020, and November 21, 2022, we recruited 70 metastatic prostate cancer patients at the Department of Clinical Oncology at Suez Canal University Hospital. Patients were eligible i...
We observed clinically significant improvements in urinary and bowel functions between baseline, 3-month, 6-month, and 12-month intervals after receiving definitive prostate radiotherapy. Patients in ...
Cytoreductive prostate radiotherapy in metastatic prostate cancer patients significantly improved urinary functioning, preserved bowel functioning but was associated with worsening of sexual functioni...
This trial was registered on (27/04/2023) with pactr.samrc.ac.za, PACTR202305854600529, URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=25510 ....
Basal cell carcinoma (BCC) of the prostate is a very rare histologic variant of prostate cancer, of difficult diagnosis and uncertain prognosis. In fact, despite the frequency of prostate cancer, only...
This study aimed to explore the diagnostic performance of miRNA-21 to differentiate between Prostate Cancer (PCa) and Benign Prostatic Hyperplasia (BPH) patients in Indonesia....
Urine samples were collected from each PCa and BPH patient. miRNA-21 relative expression against the reference gene was analyzed and compared between the two. miRNA expression was then analyzed using ...
The results of this study indicated that miRNA-21 relative expression against miRNA-16 in PCa and BPH showed 12.95 differences in fold change. Moreover, using prostate biopsy as the gold standard to d...
miRNA-21 relative expression can be used to discriminate PCa from BPH by using a urine sample. Furthermore, the expression of miR-21 has higher sensitivity than PSA; therefore, miR-21 has a high poten...
This article introduces a series of articles covering some of the most important aspects of contemporary prostate cancer care. After the introduction of the prostate-specific antigen (PSA) blood test ...